Sars-Cov-2 Virus Spike Protein vs Trastuzumab

## Sars-Cov-2 Virus Spike Protein vs Trastuzumab: Overview

This comparison examines the pharmacological differences between **Sars-Cov-2 Virus Spike Protein** and **Trastuzumab**.

## Mechanism of Action

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Sars-Cov-2 Virus Spike Protein — N/A; Trastuzumab — 28 days.

## Chemical Properties

**Type**: Sars-Cov-2 Virus Spike Protein — Vaccine component; Trastuzumab — Antibody.